Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas

Frontiers in Cardiovascular Medicine

Cardiovascular Medicine

Roberto Pola¹  Antonino Tuttolomondo²  Pasquale Pignatelli³ 

[1] Department of Geriatric, Orthopedic, and Rheumatologic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy;Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy;Department of Internal Medicine, La Sapienza University, Rome, Italy;

关键词: anticoagulation;    thrombosis;    heparin;    direct oral anticoagulant (DOAC);    vitamin K antagonist (VKA);    atrial fibrillation;    venous thromboembolism (VTE);    ischemic cardiovascular disease;   

DOI  :  10.3389/fcvm.2023.1219033

 received in 2023-05-08, accepted in 2023-09-25,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
© 2023 Tuttolomondo, Pignatelli and Pola.